486 related articles for article (PubMed ID: 32716553)
1. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
3. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
[TBL] [Abstract][Full Text] [Related]
4. Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.
Saheb Sharif-Askari F; Goel S; Saheb Sharif-Askari N; Hafezi S; Al Heialy S; Hachim MY; Hachim IY; Mahboub B; Salameh L; Abdelrazig M; Elzain EI; Al-Muhsen S; Al-Hajjaj MS; Ratemi E; Hamid Q; Halwani R
Front Immunol; 2021; 12():796094. PubMed ID: 35111161
[TBL] [Abstract][Full Text] [Related]
5. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.
Calmes D; Graff S; Maes N; Frix AN; Thys M; Bonhomme O; Berg J; Debruche M; Gester F; Henket M; Paulus V; Duysinx B; Heinen V; Dang DN; Paulus A; Quaedvlieg V; Vaillant F; Van Cauwenberge H; Malaise M; Gilbert A; Ghuysen A; Gillet P; Moutschen M; Misset B; Sibille A; Guiot J; Corhay JL; Louis R; Schleich F
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):160-169. PubMed ID: 33038592
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
[TBL] [Abstract][Full Text] [Related]
7. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.
Yao Y; Wang H; Liu Z
Clin Exp Allergy; 2020 Dec; 50(12):1313-1324. PubMed ID: 32975865
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19.
Aloufi N; Traboulsi H; Ding J; Fonseca GJ; Nair P; Huang SK; Hussain SNA; Eidelman DH; Baglole CJ
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L152-L157. PubMed ID: 33112187
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
Finney LJ; Glanville N; Farne H; Aniscenko J; Fenwick P; Kemp SV; Trujillo-Torralbo MB; Loo SL; Calderazzo MA; Wedzicha JA; Mallia P; Bartlett NW; Johnston SL; Singanayagam A
J Allergy Clin Immunol; 2021 Feb; 147(2):510-519.e5. PubMed ID: 33068560
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
11. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
Front Immunol; 2021; 12():678661. PubMed ID: 34335580
[TBL] [Abstract][Full Text] [Related]
12. Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.
Gemicioglu B; Uzun H; Borekci S; Karaali R; Kurugoglu S; Atukeren P; Sirolu S; Durmus S; Dirican A; Kuskucu MA; Tabak F
J Infect Dev Ctries; 2021 Oct; 15(10):1415-1425. PubMed ID: 34780364
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
[TBL] [Abstract][Full Text] [Related]
14. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Temsah MH; Al Heialy S; Hamid Q; Halwani R
Mol Ther Methods Clin Dev; 2020 Sep; 18():1-6. PubMed ID: 32537478
[TBL] [Abstract][Full Text] [Related]
15. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma.
Wark PAB; Pathinayake PS; Kaiko G; Nichol K; Ali A; Chen L; Sutanto EN; Garratt LW; Sohal SS; Lu W; Eapen MS; Oldmeadow C; Bartlett N; Reid A; Veerati P; Hsu AC; Looi K; Iosifidis T; Stick SM; Hansbro PM; Kicic A
Respirology; 2021 May; 26(5):442-451. PubMed ID: 33455043
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
He Y; Xie M; Zhao J; Liu X
Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
[TBL] [Abstract][Full Text] [Related]
17. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.
Gülsen A; König IR; Jappe U; Drömann D
Respirology; 2021 Jun; 26(6):552-565. PubMed ID: 33955623
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship.
Skevaki C; Karsonova A; Karaulov A; Fomina D; Xie M; Chinthrajah S; Nadeau KC; Renz H
Nat Rev Immunol; 2021 Apr; 21(4):202-203. PubMed ID: 33623123
[TBL] [Abstract][Full Text] [Related]
19. ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.
Chhapola Shukla S
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2637-2640. PubMed ID: 33025046
[TBL] [Abstract][Full Text] [Related]
20. Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium
Takahashi Y; Watanabe N; Kamio N; Yokoe S; Suzuki R; Sato S; Iinuma T; Imai K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
